课题基金 / 基金详情

Complement factor H related protein 1 (FHR1): regulator of inflammation

Complement factor H related protein 1 (FHR1): regulator of inflammation
补体 H 因子相关蛋白 1 (FHR1):炎症调节
批准号:
495061126
负责人:
Professor Dr. Olaf Strauß
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
--
资助国家:
德国
项目状态:
未结题
起止时间:

项目摘要

项目成果

Professor Dr. Olaf Strauß的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The so-called sterile inflammation is a central mechanism in degenerative diseases with large impact into public health such as age-related macular degeneration (AMD). As a basic mechanism, injured/necrotic cells or extracellular deposits trigger immune mechanisms, including cellular immune responses by mononuclear phagocytes. How this is induced is still not clear. The plasma protein Factor H related protein-1 (FHR1 in humans; FHRE in mice) recognizes these danger signals. FHR1 binds to damaged or degenerative surfaces and can then directly activate monocytes via plasma membrane receptors, CR3 and EMR2. Given these observations, we see a prominent role of FHR1 in chronic inflammatory degenerative diseases; her in AMD. We want to clarify how FHR1 binds to surfaces, activates receptors in the plasma membrane of immune competent cells, relates in plasma levels to diseases and participates in the chain of events leading to sterile inflammation and auto-inflammation in AMD. For translation, we will analyze human tissues with respect to FHR1 signaling. In preliminary studies, we found FHR1 present in Drusen in eyes of AMD patients, FHRE in mouse models for AMD. Therefore, we assume a new functional mechanism seen as FHR1-dependent inflammation in which monocytes and retinal cells with immune cell-like properties play an active role. This is supported by the fact that in AMD the chromosomal deletion of FHR1 is protective. For that reason, we aim to investigate the molecular role of FHR1 in inflammation in vitro and in vivo and expect to find a new treatment target in AMD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A role of the anoctamin membrane protein family in the homeostasis of the retina
  • 批准号:
    214855473
  • 项目类别:
    Research Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    2012
  • 负责人:
    Professor Dr. Olaf Strauß
  • 依托单位:
Untersuchungen zu funktionellen und strukturellen Eigenschaften des Bestrophin-1 und seiner pathophysiologischen Rolle bei Morbus Best
  • 批准号:
    83023808
  • 项目类别:
    Research Units
  • 资助金额:
    $0.0万
  • 财政年份:
    2008
  • 负责人:
    Professor Dr. Olaf Strauß
  • 依托单位:
Untersuchungen zu funktionellen und strukturellen Eigenschaften des Bestrophin-1 und seiner pathophysiologischen Rolle bei Morbus Best
  • 批准号:
    5437620
  • 项目类别:
    Research Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    2004
  • 负责人:
    Professor Dr. Olaf Strauß
  • 依托单位:
Age-related macular degeneration: signal transduction leading to changed secretion of angiogenic factors by retinal pigment epithelial cells from excised neovascular membranes
  • 批准号:
    5289780
  • 项目类别:
    Priority Programmes
  • 资助金额:
    $0.0万
  • 财政年份:
    2001
  • 负责人:
    Professor Dr. Olaf Strauß
  • 依托单位:
国内基金
海外基金
空气颗粒物通过调控白血病抑制因子参与影响IgA肾病进展的作用与机制研究
  • 批准号:
    82370711
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    谢静远
  • 依托单位:
缺氧诱导因子(HIF)-2α转录抑制树突状细胞CD36表达减轻肾脏缺血再灌注损伤的机制
  • 批准号:
    82370751
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    张明
  • 依托单位:
发展基因编码的荧光探针揭示趋化因子CXCL10的时空动态及其调控机制
转录因子BCL6抑制ICOSL表达优化生发中心反应的机制研究
  • 批准号:
    82371745
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    张文倩
  • 依托单位: